Beijing Tongrentang Co., Ltd (SHA:600085)
33.92
-0.10 (-0.29%)
Oct 24, 2025, 3:00 PM CST
Beijing Tongrentang Revenue
Beijing Tongrentang had revenue of 4.49B CNY in the quarter ending June 30, 2025, a decrease of -0.05%. This brings the company's revenue in the last twelve months to 18.60B, up 4.14% year-over-year. In the year 2024, Beijing Tongrentang had annual revenue of 18.60B with 4.12% growth.
Revenue (ttm)
18.60B
Revenue Growth
+4.14%
P/S Ratio
2.50
Revenue / Employee
1.04M
Employees
17,883
Market Cap
46.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18.60B | 736.39M | 4.12% |
| Dec 31, 2023 | 17.86B | 2.49B | 16.19% |
| Dec 31, 2022 | 15.37B | 769.32M | 5.27% |
| Dec 31, 2021 | 14.60B | 1.78B | 13.86% |
| Dec 31, 2020 | 12.83B | -451.24M | -3.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 42.62B |
| WuXi AppTec | 41.90B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Jiangsu Hengrui Medicine | 30.15B |
| Zhejiang NHU Company | 22.87B |
| Aier Eye Hospital Group | 21.94B |